TV-46763
Total Payments
$2.6M
Transactions
27
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $2.6M | 27 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.6M | 27 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| TV46763-AP-10027 | Teva Pharmaceuticals USA, Inc. | $2.0M | 0 |
| A Study to Investigate the Food Effect and to Evaluate the Relative Bioavailability of Three Test Formulations of TV-46763 (Hydrocodone Bitartrate and Acetaminophen Tablets, 10 mg/325 mg) CII (CIMA Labs Inc.) in Healthy Adult Subjects | Teva Pharmaceuticals USA, Inc. | $241,568 | 0 |
| TV46763-FE-10090 | Teva Pharmaceuticals USA, Inc. | $202,481 | 0 |
| TV46763-BA-10063 | Teva Pharmaceuticals USA, Inc. | $173,867 | 0 |
| TV46763-AP-10062 | Teva Pharmaceuticals USA, Inc. | $25,525 | 0 |
| TV46763-PK-10130 | Teva Pharmaceuticals USA, Inc. | $15,634 | 0 |
| TV46763-BE-10079 | Teva Pharmaceuticals USA, Inc. | $49.03 | 0 |
Top Doctors Receiving Payments for TV-46763
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Salt Lake City, UT | $2.6M | 27 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $2.6M
- Total Doctors 0
- Transactions 27
About TV-46763
TV-46763 is a drug associated with $2.6M in payments to 0 healthcare providers, recorded across 27 transactions in the CMS Open Payments database. The primary manufacturer is Teva Pharmaceuticals USA, Inc..
Payment data is available from 2017 to 2017. In 2017, $2.6M was paid across 27 transactions to 0 doctors.
The most common payment nature for TV-46763 is "Unspecified" ($2.6M, 100.0% of total).
TV-46763 is associated with 7 research studies, including "TV46763-AP-10027" ($2.0M).